These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21036106)

  • 1. Visfatin levels in female, morbid, nondiabetic obese patients after biliopancreatic diversion surgery.
    de Luis DA; Izaola O; Conde R; Primo D; Sagrado MG; Aller R
    Surg Obes Relat Dis; 2011; 7(2):195-8. PubMed ID: 21036106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistin levels in morbid obese patients following the biliopancreatic diversion surgery.
    de Luis DA; Terroba MC; Cuellar L; Conde R; Primo D; Aller R; Sagrado MG; Izaola O
    Horm Metab Res; 2011 Mar; 43(3):205-8. PubMed ID: 21264799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal GLP-1 levels in morbidly obese patients following biliopancreatic diversion surgery.
    de Luis D; Pacheco D; Conde R; Primo D; Aller R; Izaola O
    Ann Nutr Metab; 2012; 61(1):70-3. PubMed ID: 22846622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines.
    Terra X; Auguet T; Quesada I; Aguilar C; Luna AM; Hernández M; Sabench F; Porras JA; Martínez S; Lucas A; Pellitero S; Llutart J; del Castillo D; Richart C
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):691-8. PubMed ID: 22182404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.
    Araki S; Dobashi K; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Asayama K; Shirahata A
    Obesity (Silver Spring); 2008 Feb; 16(2):384-8. PubMed ID: 18239648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body fat distribution has no effect on serum visfatin levels in healthy female subjects.
    Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S
    Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G 1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion.
    de Luis DA; Pacheco D; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; Cuellar L; Terroba MC; Martin T; Ventosa M
    Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):197-201. PubMed ID: 20391958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion.
    de Luis DA; Sagrado MG; Izaola O; Terroba MC; Cuellar L; Conde R; Martin T
    Nutrition; 2008 Apr; 24(4):300-4. PubMed ID: 18280114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass.
    García-Fuentes E; García-Almeida JM; García-Arnés J; García-Serrano S; Rivas-Marín J; Gallego-Perales JL; Rojo-Martínez G; Garrido-Sánchez L; Bermudez-Silva FJ; Rodríguez de Fonseca F; Soriguer F
    Obesity (Silver Spring); 2007 Oct; 15(10):2391-5. PubMed ID: 17925464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of a moderate hypocaloric diet on visfatin levels in morbid obese patients: relationship with insulin resistance.
    De Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Castro MJ; Romero E
    Eur Rev Med Pharmacol Sci; 2010 Dec; 14(12):1031-6. PubMed ID: 21375135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up.
    García-Unzueta MT; Fernández-Santiago R; Domínguez-Díez A; Vazquez-Salví L; Fernández-Escalante JC; Amado JA
    Obes Surg; 2005 Feb; 15(2):187-90. PubMed ID: 15802059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duodenal switch: an effective therapy for morbid obesity--intermediate results.
    Baltasar A; Bou R; Bengochea M; Arlandis F; Escrivá C; Miró J; Martínez R; Pérez N
    Obes Surg; 2001 Feb; 11(1):54-8. PubMed ID: 11361169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of biliopancreatic diversion on hypertension in severely obese patients.
    Adami GF; Papadia F; Carlini F; Murelli F; Scopinaro N
    Hypertens Res; 2005 Feb; 28(2):119-23. PubMed ID: 16025738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue.
    Telejko B; Kuzmicki M; Zonenberg A; Szamatowicz J; Wawrusiewicz-Kurylonek N; Nikolajuk A; Kretowski A; Gorska M
    Diabetes Res Clin Pract; 2009 Apr; 84(1):68-75. PubMed ID: 19185944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up.
    de Luis DA; Pacheco D; Izaola O; Terroba MC; Cuellar L; Martin T
    Ann Nutr Metab; 2008; 53(3-4):234-9. PubMed ID: 19088468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass.
    Skroubis G; Sakellaropoulos G; Pouggouras K; Mead N; Nikiforidis G; Kalfarentzos F
    Obes Surg; 2002 Aug; 12(4):551-8. PubMed ID: 12194550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.
    Nannipieri M; Cecchetti F; Anselmino M; Camastra S; Niccolini P; Lamacchia M; Rossi M; Iervasi G; Ferrannini E
    Int J Obes (Lond); 2009 Sep; 33(9):1001-6. PubMed ID: 19636322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term changes in serum leptin concentration following biliopancreatic diversion.
    Marinari GM; Camerini G; Cella F; Scopinaro N; Adami GF
    Obes Surg; 2000 Oct; 10(5):442-4. PubMed ID: 11054249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.